Introduction
============

In the past decade, cardiovascular diseases (CVDs) have been the major health issues worldwide, particularly in advanced countries.[@b1-dddt-12-1311] Ischemic heart diseases (IHDs) are the main form of CVDs, and could lead to 7.2 million deaths each year.[@b2-dddt-12-1311] At present, percutaneous coronary intervention (PCI) is effective in reducing the consequences of myocardial ischemia (MI) in patients with IHDs. However, PCI therapies also frequently cause reperfusion injury. Moreover, sudden cardiac death can occur before patients have the chance of receiving preventive PCI operation. Therefore, drug treatment is still a convenient and important strategy to rescue patients from acute myocardial infarction.[@b3-dddt-12-1311],[@b4-dddt-12-1311] Development of pharmacological agents effective against IHDs is mandatory. For IHDs, prolonged ischemia and subsequent reperfusion causes severe, irreversible damage to the myocardium, resulting in thrombolysis, angioplasty, coronary bypass, and heart transplantation.[@b5-dddt-12-1311] MI is multifactorial and includes the dysfunction of energy metabolism, robust oxygen radicals, calcium overload, and inflammatory responses.[@b6-dddt-12-1311] These factors lead to changes in myocardial functional status. Among the proposed factors, oxidative stress, which had been proved to be caused by reactive oxygen species (ROS) produced in ischemia conditions,[@b7-dddt-12-1311],[@b8-dddt-12-1311] is one of the most important mechanisms. Increased reactive oxygen and nitrogen species aggravate cell apoptosis, calcium overload, and inflammatory cytokine secretion, which could promote the progression of ischemia injury. Antioxidant molecules for reducing oxidative stress are deemed to be an ideal method to protect against MI injury.[@b9-dddt-12-1311] Nrf-2, expressed in cardiomyocytes, is an important endogenous antioxidative stress regulator. As a transcription factor, Nrf-2 plays a key role in preventing the development of myocardial dysfunction and the progression of cardiac remodeling. After being phosphorylated, Nrf-2 is translocated from the cytoplasm into cell nucleus to activate the Nrf-2-dependent antioxidant response, which includes HO-1. HO-1 possesses anti-inflammatory, antiapoptotic, antiproliferative, and especially cytoprotective effects.[@b3-dddt-12-1311] Its activation has been demonstrated to be related with many CVDs.[@b10-dddt-12-1311] It is thought to be an important potential target for curing some CVDs. Hence, upregulation of the Nrf-2/HO-1 pathway may play a therapeutic role in attenuating MI injury.

Glycyrrhizic acid (GA), also known as glycyrrhizin, is one of the important active compounds isolated from the root of licorice. GA has a variety of pharmacological activities, such as being an anti-inflammatory, antiulcer, antiallergy, antioxidation, immune regulatory, antiviral, and anticancer agent, helping in liver protection, and so on.[@b11-dddt-12-1311] Furthermore, its promotion of Nrf-2 activity was also described in previous papers.[@b12-dddt-12-1311] GA is reported to relieve cardiac ischemia in rats.[@b13-dddt-12-1311] However, it was not clear that whether GA attenuated MI injury through activating Nrf-2. Therefore, the purpose of present study was to investigate whether GA ameliorates MI injury, and to assess the role of Nrf2/ARE signaling pathway in the cardioprotective effect of GA.

Materials and methods
=====================

Reagents
--------

GA was purchased from National Institutes for Food and Drug Control (Beijing, People's Republic of China). Diltiazem (Dit) was obtained from Simcere Pharmaceutical Group (Nanjing, People's Republic of China). Isoproterenol (ISO) hydrochloride injection was provided by Hongta Tobacco Group Company Limited (Yuxi, People's Republic of China). TNF-α, IL-6, and IL-1β enzyme-linked immunosorbent assay (ELISA) kits were supplied by Nanjing KeyGEN Biotech. Co., Ltd. (Nanjing, People's Republic of China). Malondialdehyde (MDA) and superoxide dismutase (SOD) commercial kits were purchased from Jiancheng Bioengineering Institute (Nanjing, People's Republic of China). Antibodies against IκB, p-IκB, NF-κB, and p-NF-κB were produced by Cell Signaling Technology (Danvers, MA, USA).

Animals
-------

Fifty adult male Sprague Dawley rats (weighing 200--250 g) were provided by the Comparative Medicine Centre of Yangzhou University. All the rats were maintained at a constant temperature of 25°C±2°C in the Animal Center of China Pharmaceutical University. All the animals were kept on a 12 h light/12 h dark cycle and provided with standard water and food pellets ad libitum. All the experimental procedures were carried out in accordance with the National Institutes of Health Guidelines. All animal experiments were approved by the animal and ethics review committee of Nanjing University of Chinese Medicine, People's Republic of China.

Experimental protocol
---------------------

Experimental rats were randomly divided into five groups (n=10) as follows: 1) control group, 2) ISO group, 3) ISO+Dit (10 mg/kg) group (positive control), 4) ISO+GA (10 mg/kg) group, and 5) ISO+GA (20 mg/kg) group. Rats in the administration groups were intraperitoneally pretreated with GA (10 and 20 mg/kg) and Dit (10 mg/kg) for 7 days. Afterward, the animals in all groups, except for the control group, were administrated with ISO (80 mg/kg) by subcutaneous injection on two consecutive days. The rats in the control group were given equal volumes of saline at the same time. Twenty-four hours after ISO administration, the rats were anesthetized by CO~2~ asphyxiation, and electrocardiogram (ECG) was taken. After that, the animals were sacrificed, and the blood was collected and processed for further biochemical assays. The hearts tissue were excised and rinsed in ice-cold isotonic saline.

ECG assessment
--------------

The ECG were recorded with an ECG recording and analysis system (BL-420F, Chengdu TME Technology Company, Chengdu, People's Republic of China).

Cardiac marker enzymes
----------------------

After the ECG detection, arterial blood samples were collected and centrifuged at 3,500 rpm for 15 min to obtain serum, and then stored at −80°C. Serum samples were thawed at room temperature before analysis. Myocardial damage was evaluated by measuring the serum levels of creatine kinase (CK-MB) and lactate dehydrogenase (LDH) with RT-9600 Semiautomatic Biochemical Analyzer (ShenZhenLeiDu Life Science, LLC, ShenZhen, People's Republic of China).

Antioxidant enzymes assay
-------------------------

The levels of oxidative stress markers, MDA, and the activities of antioxidants markers, SOD, were measured using commercial kits according to the manufacturer's protocols.

Inflammation assay
------------------

To explore the relationship between the cardioprotective effects of GA and the levels of inflammatory cytokines, IL-6, IL-1β, and TNF-α levels in the serum were evaluated with ELISA kits. All experimental procedures were performed according to the kit manufacturer's instructions.

Histological studies
--------------------

The fresh heart tissues (left cardiac apex, the ischemic part) were fixed in 10% formalin solution and embedded in paraffin for histopathological analysis. Then, the sections were processed for sectioning and stained with hematoxylin and eosin by standard histological methods. Afterward, the histopathological changes were examined by light microscopy (Nikon, Tokyo, Japan) at 200× magnification.

Western blot analysis
---------------------

Heart tissues (left cardiac apex, the ischemic part) were homogenized in lysis buffer containing 1 mL of RIPA and 10 μL of PMSF. The protein was quantified using BCA kit. Protein samples were loaded on 12% SDS-PAGE and transferred to polyvinylidene fluoride membranes (Bio-Rad Laboratories, Hercules, CA, USA). The membranes were blocked with 5% milk for 2 h and washed with TBST three times. The membranes were incubated with primary antibodies, which included antibodies against Nrf2 (1:1,000), HO-1 (1:1,000), p-IκB (1:1,000), IκB (1:1,000), p-NFκB (1:1,000), and NF-κB (1:1,000), overnight at 4°C. After washing, the blots were incubated with HRP-labeled secondary antibodies for 2 h. Immunoblots were visualized using the ECL detection system and a gel imaging system.

Statistical analysis
--------------------

All statistical results are expressed as mean ± SD. Significant differences were checked by one-way analysis of variance followed by Tukey multiple comparison tests. *p*\<0.05 was considered significant.

Results
=======

Effects of GA on ST-segment
---------------------------

When the blood flow through the heart muscle is decreased by a partial or complete blockage of heart arteries, MI occurs and causes ST level changes in an ECG signal. A normal ST-segment is characterized by its horizontal nature, whereas an abnormal ST-segment deviates from the horizontal path.[@b13-dddt-12-1311] In this study, 24 h after ISO administration, ST-segment elevation was recorded by lead II ECG. The ECG patterns in each group are shown in [Figure 1](#f1-dddt-12-1311){ref-type="fig"}. As seen in [Figure 1](#f1-dddt-12-1311){ref-type="fig"}, there was remarkable elevation in ST-segment in the model group compared with the control group, suggesting that the MI damage model has been established. The administration of GA induced a statistically significant reduction in ST-segment elevation as compared with the vehicle group in a dose-dependent manner (*F*(4, 30) =21.43, *p*\<0.01) ([Figures 1](#f1-dddt-12-1311){ref-type="fig"} and [2](#f2-dddt-12-1311){ref-type="fig"}). These results reflect the positive effect of GA on cardiac function.

Effects of GA on CK and LDH
---------------------------

CK and LDH have been identified as essential diagnostic markers of myocardial injury and leak out from damaged myocardium to blood.[@b14-dddt-12-1311] Current studies measured the amounts of CK and LDH in serum to evaluate the myocardial damage. As shown in [Figure 3](#f3-dddt-12-1311){ref-type="fig"}, a marked increase in the levels of CK and LDH were detected in MI model group rats compared with those in the control group (*F*(4, 30) =76.56, *p*\<0.01). But, compared with the model group, the GA significantly decreased serum CK and LDH at a dose of 10 and 20 mg/kg (*F*(4, 30) =26.48, *p*\<0.01).

Effects of GA on SOD and MDA
----------------------------

In this study, we evaluated the levels of SOD and MDA in the serum to explore the relationship between the cardioprotective effect of GA in MI and its antioxidant status. As shown in [Figure 3](#f3-dddt-12-1311){ref-type="fig"}, compared with control group, the model rats exhibited a significant increase in MDA content, while the level of SOD was significantly decreased, and those changes were reversed in GA and Dit groups (SOD, *F*(4, 30) =12.33, *p*\<0.01; MDA, *F*(4, 30) =12.25, *p*\<0.01). These results suggested the antioxidative stress effect of GA in alleviating MI injury.

Effects of GA on TNF-α, IL-1β, and IL-6
---------------------------------------

Myocardial ischemic injury was characterized by increased levels of inflammatory factors such as TNF-α, IL-1β, and IL-6. To further evaluate and validate the protective function of GA during MI injury, we measured the levels of TNF-α, IL-1β, and IL-6 in serum. It was noted that there was a marked increase in the levels of the TNF-α, IL-1β, and IL-6 as compared with that of rats in the control group (TNF-α, *F*(4, 30) =11.13, *p*\<0.01; IL-1β, *F*(4, 30) =13.92, *p*\<0.01; IL-6, *F*(4, 30) =15.45, *p*\<0.01, [Figure 4](#f4-dddt-12-1311){ref-type="fig"}). Notably, the administration of GA (10 and 20 mg/kg) and Dit could inhibit the increase, which indicated that GA and Dit significantly suppressed MI-induced inflammatory cytokine secretion in the serum.

Effects of GA on myocardial histology
-------------------------------------

Physiological impairment of myocardium tissue in the rats is illustrated in [Figure 5](#f5-dddt-12-1311){ref-type="fig"}. The myocardial tissues from control rat myocardium exhibited a regular integrity of myocardial structure, normal cardiac muscle fibers, and no necrosis. However, compared with the control group, the model group demonstrated abnormal morphological changes which the occurrence of suggested myocardial injury. These changes included myocardial cell swelling, degeneration, transverse striation loss, and inflammatory cells infiltration. The myocardial damage in the GA groups was less than that in the model group. Cardiac sections obtained from rats undergoing GA treatment presented a relatively more intact and less myocardial fiber disruption, necrosis, and inflammatory cell infiltration compared with those from the model group. The histopathological results confirmed that GA could attenuate ISO-induced MI in rats.

Effects of GA on the expression of proteins in Nrf-2/HO-1 and NF-κB pathways
----------------------------------------------------------------------------

Nrf2, HO-1, and NF-κB signaling are the well-known cytoprotective target mediating oxidative stress and inflammation. To clarify whether the Nrf-2/HO-1 and NF-κB pathways were involved in the cardioprotective effect of GA in MI, the expression level of proteins related to Nrf2, HO-1, and NF-κB signaling in the ischemic areas of myocardial tissue were detected by Western blots. As revealed in [Figure 6](#f6-dddt-12-1311){ref-type="fig"}, exposure to ISO notably inhibited the protein expressions of HO-1 and Nrf2. However, after treating with GA (10 and 20 mg/kg) and Dit (10 mg/kg), the protein expressions of HO-1 and Nrf2 was significantly enhanced compared with those in ISO group. In addition, ISO challenge contributed to the upregulations of phosphorylated IκB and NF-κB, while the treatment with GA (10 and 20 mg/kg) and Dit (10 mg/kg) effectively downregulated the levels of p-IκB and p-NF-κB.

Discussion
==========

MI remains the large cause of morbidity and mortality for an increasing proportion of the world's population. Evidence has emerged indicating that MI injury result due to hypoxia is linked with diminished energy supply and oxidative stress.[@b15-dddt-12-1311] ISO is a synthetic β-adrenergic agonist that can cause increased myocardial oxygen consumption and necrosis of heart muscle cells.[@b16-dddt-12-1311] Large doses of ISO administered in rats can induce acute MI. So in the current study, we build the acute MI induced by ISO. The acute MI induced by ISO was confirmed by ST-segment elevation, loss of integrity of myocardial membranes on histological examination, and serum elevation of CK and LDH enzymes. Pretreatment with GA reduced the ST-segment elevation induced by acute MI and alleviated myocardial ischemic injury. GA also decreased CK, LDH, MDA, IL-1β, TNF-α, and IL-6 levels, and increased SOD activity. These results suggested that GA in the doses used in this study exhibited cardioprotective effects in MI, which could be attributed to its antioxidative and anti-inflammatory properties.

Free radical generation and consequent oxidative stress in ischemia leads to tissue damage, which is accompanied by activation of the inflammatory responses. Previous research has demonstrated that oxidative stress is one of the key mechanisms playing a role in the process of myocardial ischemic injury.[@b17-dddt-12-1311] Oxidative stress can damage cellular macromolecules, inducing protein modification, lipid peroxidation, as well as DNA damage.[@b18-dddt-12-1311] The levels of SOD and MDA activity are two principal pathophysiological parameters for evaluating free radical metabolism. SOD is an important antioxidant enzyme to alleviate myocardial injury and reflects the cellular capability of scavenging/quenching free radicals.[@b19-dddt-12-1311] In this study, SOD activity was significantly decreased in the ISO-treated rats as compared to controls. Administration of GA significantly restored SOD activity and reduced the content of MDA, which suggested that the cardioprotective effect of GA were related to antioxidative properties.

Previous studies showed that excessive oxidative stress contributed to overexpressions of multiple cytokines, such as TNF-α, IL-6, and IL-1β. The elevated levels of inflammatory markers were associated with MI.[@b20-dddt-12-1311] IL-6, released from vascular endothelial cells, aggravates the progress of inflammatory response and inhibits infiltration of neutrophils.[@b21-dddt-12-1311] During inflammatory disease procedures, TNF-α and IL-1β are pleiotropic to control rheumatoid arthritis disease progression. The elevation of IL-1β promoted the apoptosis of cardiomyocytes and upregulated the expression of matrix metalloproteinases.[@b22-dddt-12-1311] Thus, TNF-α, IL-6, and IL-1β are important inflammatory mediators in regulating inflammatory response procedures. In this study, the inflammatory stresses induced by ISO were reflected by serum IL-6, IL-1β, and TNF-α elevations. GA preconditioning decreased the levels of proinflammatory cytokines, which suggested that the cardioprotective effects of GA were also associated with anti-inflammatory properties.

In MI injury, oxidative stress is induced by an excess of intracellular oxidants or ROS. Since endogenous antioxidant proteins can eliminate intracellular oxidants and ROS, the antioxidant proteins play an important role in antioxidant stress.[@b23-dddt-12-1311] Therefore, improving the expression of endogenous antioxidant proteins could be an effective strategy to reduce myocardial cell damage. Recent evidence indicates that Nrf2 is a key regulator of endogenous antioxidant systems.[@b24-dddt-12-1311] Nrf-2 activates endogenous antioxidant enzymes to reduce oxidative stress. During the procedures, Nrf-2 dissociates from Keap1, binds to the ARE, and activates phase II enzymes such as HO-1.[@b25-dddt-12-1311],[@b26-dddt-12-1311] The rate-limiting enzyme HO-1 is considered as a stress protein, which is a sensitive indicator of oxidative stress in the myocardium. MI also results in significant cardiac dysfunction owing to the increase of inflammation-related genes expressions. NF-κB has been identified to be a pivotal regulator of inflammatory signaling pathways to produce proinflammatory cytokines.[@b27-dddt-12-1311] In an inactive state, NF-κB resides in the cytoplasm, where it associates with an inhibitory protein, IκB.[@b28-dddt-12-1311] Upon activation, the NF-κB subunit p65 was promoted via the phosphorylation and degradation of the IκB.[@b29-dddt-12-1311] In the current study, we discussed the interlinkage between Nrf-2 and NF-κB. The activation of Nrf-2 was accompanied by the production of HO-1. As a key mediator in inflammation response, NF-κB promoted the elevation of nitric oxide after its activation. Abass et al[@b31-dddt-12-1311] previously found that Nrf-2 upregulation was related to the inhibition of NF-κB translocation by HO-1 end products, including bilirubin and CO.[@b30-dddt-12-1311] Although GA has been reported previously to relieve cardiac ischemia in rats,[@b13-dddt-12-1311] it was not clear that whether GA attenuated MI injury through regulating Nrf-2 and NF-κB pathways. To further explore the mechanisms of GA protective effect on MI rats, we examined the effects of GA on the activation of the Nrf-2/HO-1 and NF-κB signaling pathways. The Western blot data displayed that GA treatment effectively upregulated HO-1 and Nrf2 expressions and downregulated the phosphorylation of IκB and NF-κB caused by ISO challenge. In Cao and Wu's work, GA showed activities as inducers of Nrf2 and inhibitors of NF-κB activation in the liver and the kidney. To the best of our knowledge, our work is the first to study the regulation of GA on Nrf-2 and NF-κB pathways in myocardial tissue. Taken together, the current data confirmed that GA exhibited remarkable protective effects on ISO-induced MI through suppressing oxidative stress and inflammatory cytokines. In addition, GA could activate the Nrf2 antioxidant response and inhibit NF-κB activation, which may be partly associated with its protective effect in ISO-induced oxidative stress and inflammatory responses. These findings suggest that GA could be developed as potential, efficient therapeutic drug against MI in the future. However, further, more comprehensive studies are warranted to explore its future clinical application.
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![Statistical analysis of GA on ST-segment elevation.\
**Notes:** Values are expressed as mean ± SD. ^\#\#^*p*\<0.01 vs control group. \*\**p*\<0.01 vs ISO group.\
**Abbreviations:** Dit, diltiazem; GA, glycyrrhizic acid; ISO, isoproterenol; SD, standard deviation.](dddt-12-1311Fig2){#f2-dddt-12-1311}

![Effects of GA on serum levels of CK, LDH, SOD, and MDA.\
**Notes:** Values represent the mean ± SD and are representative of two independent experiments. ^\#\#^*p*\<0.01, vs control group; \*\**p*\<0.01 vs ISO group.\
**Abbreviations:** CK, creatin kinase; Dit, diltiazem; GA, glycyrrhizic acid; LDH, lactate dehydrogenase; ISO, isoproterenol; MDA, malondialdehyde; SD, standard deviation; SOD, superoxide dismutase.](dddt-12-1311Fig3){#f3-dddt-12-1311}

![Effects of GA on serum proinflammatory cytokines.\
**Notes:** ^\#\#^*p*\<0.01, vs control group; \*\**p*\<0.01 vs ISO group.\
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![Effects of GA on histopathological lesions.\
**Notes:** (**A**) control group, (**B**) model (ISO) group, (**C**) the ISO+Dit (10 mg/kg) group, (**D**) ISO+GA (10 mg/kg) group, and (**E**) ISO+GA (20 mg/kg) group (hematoxylin and eosin staining, magnification 200×).\
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![Effects of GA on Nrf-2/HO-1 pathway-related proteins in rats.\
**Notes:** Values are expressed as mean ± SD. ^\#\#^*p*\<0.01 vs control group. \*\**p*\<0.01 vs ISO group.\
**Abbreviations:** Dit, diltiazem; GA, glycyrrhizic acid; ISO, isoproterenol; SD, standard deviation.](dddt-12-1311Fig6){#f6-dddt-12-1311}
